Clinical Trials Logo

Clinical Trial Summary

Hypoxaemic patients with exacerbations of chronic obstructive pulmonary disease (COPD) are at some risk of carbon dioxide (CO2) retention during oxygen therapy. Main mechanism of CO2 retention is believed to be reversal of preexisting regional hypoxic pulmonary vasoconstriction, resulting in a greater dead space. Risk of CO2 retention during mechanical ventilation remains controversial. Thus recent study suggested limited risk of CO2 retention with controlled oxygen supplementation during mechanical ventilation. Conversely, controlled oxygen supplementation might decrease dyspnea and respiratory workload, increase comfort and improve both urinary output and renal function.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02563314
Study type Interventional
Source Centre Hospitalier Universitaire de Saint Etienne
Contact
Status Terminated
Phase N/A
Start date March 22, 2017
Completion date September 24, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05905874 - Machine Learning-based Models in Prediction of DVT and PTE in AECOPD Patients